Skip to main content
Livermore
Livermore
ZHEN

Emerald Advisers, LLC

SEC CIK
0001015083
Latest filing
Aug 5, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
920
Value
$276.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ALNY by Emerald Advisers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026920$276.9K<0.1%−702−43.3%ReducedHolders
Q1 20261,622$536.7K<0.1%00.0%UnchangedHolders
Q4 20251,622$645.0K<0.1%−73−4.3%ReducedHolders
Q3 20251,695$772.9K<0.1%−246−12.7%ReducedHolders
Q2 20251,941$632.9K<0.1%+445+29.7%AddedHolders
Q1 20251,496$403.9K<0.1%−84−5.3%ReducedHolders
Q4 20241,580$371.8K<0.1%+3+0.2%AddedHolders
Q3 20241,577$433.7K<0.1%−41−2.5%ReducedHolders
Q2 20241,618$393.2K<0.1%−452−21.8%ReducedHolders
Q1 20242,070$309.4K<0.1%−24−1.1%ReducedHolders
Q4 20232,094$400.8K<0.1%−925−30.6%ReducedHolders
Q3 20233,019$534.7K<0.1%−67−2.2%ReducedHolders
Q2 20233,086$586.2K<0.1%−46−1.5%ReducedHolders
Q1 20233,132$627.4K<0.1%+575+22.5%AddedHolders
Q4 20222,557$607.7K<0.1%−43−1.7%ReducedHolders
Q3 20222,600$520.0K<0.1%−21−0.8%ReducedHolders
Q2 20222,621$382.0K<0.1%−315−10.7%ReducedHolders
Q1 20222,936$479.0K<0.1%−54−1.8%ReducedHolders
Q4 20212,990$507.0K<0.1%−42−1.4%ReducedHolders
Q3 20213,032$572.0K<0.1%−1,057−25.8%ReducedHolders
Q2 20214,089$693.0K<0.1%00.0%UnchangedHolders
Q1 20214,089$577.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.